No Data
No Data
Galapagos NV Unveils New Employee Incentive Plans
Galapagos Creates New Subscription Right Plans
Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV ((Euronext &, NASDAQ:GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right
Galapagos NV Expands U.S. CAR-T Therapy Production
Galapagos Partners With Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture
Galapagos (GLPG.AS) said Wednesday that it is collaborating with Blood Centers of America to decentralize the manufacture of its CAR-T cell therapies. The Belgian pharmaceutical research company will
Galapagos and Blood Centers of America Announce Strategic Collaboration to Accelerate Galapagos' Decentralized CAR-T Manufacturing Network in the U.S.
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of
Kepler Capital Sticks to Their Hold Rating for Galapagos (GLPG)